Cédric Menard
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 24
- Immune Cell Function and Interaction 17
- Immunotherapy and Immune Responses 10
- T-cell and B-cell Immunology 9
- Genetics 19
- Mesenchymal stem cell research 14
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- François Ghiringhelli (8 shared papers)Laurence Zitvogel (14 shared papers)François Martin (3 shared papers)S. Roux (3 shared papers)Axel Le Cesne (2 shared papers)Éric Solary (1 shared paper)Sylvain Ladoire (1 shared paper)Bruno Chauffert (1 shared paper)
- Journals
- Blood (8 papers)Cancer Immunology Immunotherapy (3 papers)The Journal of Immunology (3 papers)Stem Cells (2 papers)Cancer Research (2 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Cédric Menard
44 papers receiving 2.8k citations
Cédric Menard's Hit Papers
Peers
Comparison fields: 5 of 102
- Immunology 1.5k
- Oncology 1.3k
- Genetics 497
- Hematology 166
- Pathology and Forensic Medicine 230
Countries citing papers authored by Cédric Menard
This map shows the geographic impact of Cédric Menard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Menard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Menard more than expected).
Fields of papers citing papers by Cédric Menard
This network shows the impact of papers produced by Cédric Menard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Menard. The network helps show where Cédric Menard may publish in the future.
Co-authors
The 25 scholars most cited alongside Cédric Menard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients Hit paper breakdown → | 2006 | 968 |
| 2 | 2006 | 216 | |
| 3 | 2009 | 161 | |
| 4 | 2006 | 159 | |
| 5 | 2013 | 154 | |
| 6 | 2008 | 129 | |
| 7 | 2012 | 110 | |
| 8 | 2008 | 85 | |
| 9 | 2013 | 67 | |
| 10 | 2019 | 60 | |
| 11 | 2013 | 58 | |
| 12 | 2015 | 50 | |
| 13 | 2020 | 49 | |
| 14 | 2008 | 39 | |
| 15 | 2008 | 35 | |
| 16 | 2014 | 33 | |
| 17 | 2018 | 33 | |
| 18 | 2017 | 33 | |
| 19 | 2017 | 30 | |
| 20 | 2011 | 29 |
About Cédric Menard
Cédric Menard is a scholar working on Immunology, Genetics, Oncology, Surgery and Pathology and Forensic Medicine, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (17 papers), Mesenchymal stem cell research (14 papers), Immunotherapy and Immune Responses (10 papers), T-cell and B-cell Immunology (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers), CAR-T cell therapy research (5 papers) and Tissue Engineering and Regenerative Medicine (4 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.3k citations), Genetics (497 citations), Hematology (166 citations) and Pathology and Forensic Medicine (230 citations). Cédric Menard has collaborated with scholars based in France, Italy and United States. Frequent co-authors include François Ghiringhelli, Laurence Zitvogel, François Martin, S. Roux, Axel Le Cesne, Éric Solary, Sylvain Ladoire, Bruno Chauffert, Karin Tarte and Nathalie Chaput. Their work appears in journals such as Blood, Cancer Immunology Immunotherapy, The Journal of Immunology, Stem Cells and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.